NCT04415983 Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
| NCT ID | NCT04415983 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Tanta University |
| Condition | Helicobacter Pylori Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-06-01 |
| Primary Completion | 2030-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 100 participants in total. It began in 2020-06-01 with a primary completion date of 2030-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
Eligibility Criteria
Inclusion Criteria: \- Positive helicobacter infection. Exclusion Criteria: * Previous treatment for H. Pylori.
Contact & Investigator
Rasha Gamal, Ass. Prof.
PRINCIPAL INVESTIGATOR
Pediatrics department - Tanta University
Frequently Asked Questions
Who can join the NCT04415983 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Helicobacter Pylori Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04415983 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 100 participants.
Is NCT04415983 currently recruiting?
Yes, NCT04415983 is actively recruiting participants. Contact the research team at sheriefabdelsalam@yahoo.com for enrollment information.
Where is the NCT04415983 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT04415983 clinical trial?
NCT04415983 is sponsored by Tanta University. The principal investigator is Rasha Gamal, Ass. Prof. at Pediatrics department - Tanta University. The trial plans to enroll 100 participants.